Explore All 1514 Add-on Acquisition Chemicals Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | June 7, 2021 |
| Target | Molecular Products |
| Sector | Chemicals |
| Buyer(s) | Filtration Group |
| Sellers(s) | Arlington Capital Partners |
| Deal Type | Add-on Acquisition |
FILTER BY
| Category | Company |
|---|---|
| Founded | 1942 |
| Sector | Manufacturing |
| Revenue | 1.3B USD (2017) |
Filtration Group designs and manufactures filtration systems and components for applications in healthcare, life sciences, environmental safety, and industrial processes. Filtration Group’s portfolio includes air, liquid, and process filtration solutions used across global markets to improve air quality, product purity, and equipment efficiency.. Filtration Group was founded in 1942 and is based in Austin, Texas.
| Deal Context for Buyer | # |
|---|---|
| Overall | 17 of 17 |
| Sector: Chemicals | 1 of 1 |
| Type: Add-on Acquisition | 12 of 12 |
| Country: United Kingdom | 2 of 2 |
| Year: 2021 | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-05-26 |
Oxyphen
Wetzikon, Switzerland Oxyphen is a manufacturer of microporous track-etched membranes which are used in the pharmaceutical, biotechnology and transportation industries for drug discovery, cell growth, tissue engineering, drug delivery and sensor technology. Oxyphen was founded in 1969 and is based in Wetzikon, Switzerland. |
Buy | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 1999 |
| PE ASSETS | 14.0B USD |
| Size | Mega |
| Type | Sector Agnostic |
Arlington Capital Partners is a middle-market private equity firm focused on buyouts and recapitalizations in targeted growth industries. Arlington targets US based companies valued between $50 and $500 million with strong potential for organic growth and possible consolidation opportunities. Sectors of interest include business services and outsourcing, aerospace/defense, federal and commercial IT, media, education and training, healthcare services, and manufacturing. Arlington Capital was formed in 1999 and is headquartered in Washington DC.
| Deal Context for Seller | # |
|---|---|
| Overall | 32 of 43 |
| Sector: Chemicals | 1 of 1 |
| Type: Add-on Acquisition | 16 of 22 |
| Country: United Kingdom | 2 of 2 |
| Year: 2021 | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-12-07 |
Everest Clinical Research
Markham, Ontario, Canada Everest Clinical Research is a contract research organization (“CRO”) providing a comprehensive suite of mission-critical clinical research services to the worldwide pharmaceutical, biotechnology, and medical device industries across Phase I-IV trials. Everest Clinical Research was founded in 2004 and is based in Markham, Ontario. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-07-12 |
TRP Infrastructure Services
Fort Worth, Texas, United States TRP Infrastructure Services is a construction company that provides roadway infrastructure support including pavement marking, traffic control, guardrail installation, and related roadway safety services for public agencies and contractors. The Company serves state and local transportation departments and private sector clients with on-site traffic management and permanent signage solutions. TRP Infrastructure Services was founded in 2010 and is based in Fort Worth, Texas. |
Buy | - |
